The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

Share Price Information for Carrs Group (CARR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 131.00
Ask: 134.00
Change: -2.00 (-1.50%)
Spread: 3.00 (2.29%)
Open: 133.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
CARR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Animax Limited

21 Sep 2018 07:00

RNS Number : 4794B
Carr's Group PLC
21 September 2018
 

 

 

 

 

 

CARR'S GROUP PLC ("Carr's" or the "Group")

Acquisition of Animax Limited

Carr's Group bolsters its position in animal health with key acquisition

 

 

21 September 2018: Carr's (CARR.L), the Agriculture and Engineering Group, announces the acquisition of the entire issued share capital of Animax Limited ("Animax"), a producer of market-leading animal health products, for a total cash consideration of up to £8.5m.

 

Animax, based in Suffolk in the UK, was established in 1982. The business specialises in the research, development and manufacture of highly effective animal health products. Animax is at the forefront of innovation in the field of livestock trace element supplementation. Its patent-protected leaching boluses, currently sold in the UK and overseas under the Tracesure® and Allsure® brands, are specifically designed to deliver health benefits to livestock consistently over prolonged periods.

 

Animax also produces other leading animal health and trace element supplementation products sold under well-known brands including Copasure®, Copinox®, Coprac®, Easycal®, Pardevit® and Paracide®.

 

Highlights and strategic rationale of the acquisition:

 

The acquisition of Animax aligns with the Group's stated strategy of investing in growing agriculture markets in the UK and internationally.

 

In particular, Animax and its product ranges:

 

· enhance the Group's position in the global animal health and livestock supplementation markets;

· bring innovation and patent-protected technology to the Group together with a number of recognised and highly respected brands;

· are highly complementary to, and will benefit from clear synergies with, the established Carr's Group feed block business across the USA, NZ, Europe, UK and Ireland; and

· broaden the Group's animal health and supplementation product ranges which bring added value to farmers.

 

Carr's will support the growth and development of Animax through investment in research to develop new products and by investing in manufacturing efficiencies. In addition, Carr's expects significant manufacturing, distribution and sales synergy benefits to be realised as a result of the acquisition.

 

As part of the acquisition, Carr's has also acquired the entire issued share capital of Animax's related party, Clinimax Limited ("Clinimax"). Clinimax is a manufacturer of specialist disinfectant products for use in the medical industry and which also carry the benefit of patent-protection.

 

Both businesses are being acquired for an initial cash consideration of £6m, with an additional cash consideration of up to a maximum of £2.5m payable over the period to November 2020, based on the achievement of agreed financial targets.

 

For the year ended 30 November 2017, Animax and Clinimax in aggregate recorded EBITDA of £0.6m and profit before tax of £0.3m. The combined gross assets of Animax and Clinimax as at 30 November 2017 totalled £5.6m, including cash of £1.2m. The acquisition is expected to be earnings enhancing in the first full year of ownership. The total consideration is being satisfied by the Group's existing facilities.

 

Tim Davies, Chief Executive, commented:

 

"We are delighted to announce the acquisition of Animax. This acquisition is in line with our stated strategy of developing our offering in the growing livestock specialist nutrition market both in the UK and internationally. Animax is highly complementary to our global feed block business and will add value to our customers' businesses. Animax has a history of developing market leading products based on sound research with their brands being recognised for their efficacy and performance. The combination of Carr's resources, knowledge and distribution, together with the Animax research capability, product technology and history of innovation, make a compelling case for this strategic step for the Group."

 

 

 

 

Enquiries:

Carr's Group plc

Tim Davies (Chief Executive)

Neil Austin (Group Finance Director)

 

Tel: +44 (0) 1228 554 600

Powerscourt

Nick Dibden / Lisa Kavanagh / Sam Austrums

 

Tel: +44 (0) 20 7250 1446

 

About Carr's Group plc:

Carr's is an international leader in manufacturing value added products and solutions, with market leading brands and robust market positions in Agriculture and Engineering, supplying customers in over 50 countries around the world.

Its Agriculture division manufactures and supplies feed blocks and supplementation products for livestock, distributes farm machinery and runs a UK network of rural stores, providing a one-stop shop for the farming community. Its Engineering division designs and manufactures bespoke equipment and provides technical engineering services into the nuclear, petrochemical, oil and gas, pharmaceutical, process and renewable energy industries, including robotic and remote handling equipment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGMGZLGGKGRZZ
Date   Source Headline
31st Mar 20224:26 pmRNSTotal Voting Rights
25th Mar 20222:07 pmRNSTR-1: Notification of major holdings
28th Feb 202211:43 amRNSTotal Voting Rights
9th Feb 20227:00 amEQSCarr's Group (CARR): Optimising value for shareholders
2nd Feb 20222:53 pmRNSTR1: Notification of major holdings
1st Feb 20229:42 amRNSTotal Voting Rights
28th Jan 20223:10 pmRNSTR1: Notification of major holdings
24th Jan 20224:37 pmRNSPrice Monitoring Extension
18th Jan 20222:59 pmRNSResult of AGM
18th Jan 20227:00 amRNSTrading Update
14th Jan 20227:00 amRNSArrangements for 2022 AGM
12th Jan 20221:21 pmRNSBlock Listing
5th Jan 20224:17 pmRNSTR1: Notification of major holdings
29th Dec 20214:35 pmRNSPrice Monitoring Extension
21st Dec 202110:56 amRNSDirector/PDMR Shareholding
20th Dec 202111:19 amRNSBlock Listing
20th Dec 202111:15 amRNSBlock Listing
15th Dec 202112:28 pmRNSNotice of AGM
14th Dec 20211:12 pmRNSDirector / PDMR Shareholding
13th Dec 20214:49 pmRNSDirector/PDMR Shareholding
13th Dec 20214:40 pmRNSDirector/PDMR Shareholding
7th Dec 20217:00 amRNSFull Year Results
2nd Dec 20213:45 pmRNSTR1: Notification of major holdings
30th Nov 20212:42 pmRNSTotal Voting Rights
17th Nov 202112:57 pmRNSFY21 Full Year Results: Revised Date
16th Nov 20214:21 pmRNSDIRECTOR ANNOUNCEMENT UNDER LR 9.6.11
29th Oct 20212:19 pmRNSTotal Voting Rights
12th Oct 20217:00 amRNSBoard Change
1st Oct 20214:24 pmRNSTR-1: Notification of Major Holdings
30th Sep 20215:12 pmRNSTotal Voting Rights
24th Sep 20217:00 amRNSNon-Executive Director Change
2nd Sep 20214:17 pmRNSTR-1: Notification of Major Holdings
31st Aug 202110:01 amRNSTotal Voting Rights
23rd Jul 20219:40 amRNSDirector / PDMR Shareholding
19th Jul 20217:00 amRNSTrading Update
30th Jun 202111:06 amRNSBlock Listing Six Monthly Return
30th Jun 202111:05 amRNSBlock Listing Six Monthly Return
30th Jun 20219:46 amRNSTotal Voting Rights
16th Jun 20214:42 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
12th May 20219:22 amRNSHolding(s) in Company
30th Apr 20219:48 amRNSTotal Voting Rights
21st Apr 202110:51 amRNSDirector / PDMR Shareholding
21st Apr 20217:00 amRNSInterim Results
7th Apr 20217:00 amRNSNotice of Interim Results
1st Apr 202112:52 pmRNSTotal Voting Rights
26th Feb 20213:33 pmRNSTotal Voting Rights
15th Feb 202112:09 pmRNSDirector / PDMR Shareholdings
11th Feb 20214:41 pmRNSSecond Price Monitoring Extn
11th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.